Quantcast:
 |
#424146. Affymax, Inc.
Investigating a new treatment alternative for anemia management. Affymax is a biopharmaceutical company developing drugs to improve the treatment of serious and often life-threatening conditions. The company’s product candidate, Hematide™, is being evaluated to treat anemia associated with chronic renal failure.
Affymax.com ~
Site Info
Whois
Trace Route
RBL Check
|
|
|
|